CliffBio
biologic

Enbrel

etanercept

Loss of exclusivity—loss of exclusivity
CompanyImmunex Corporation

Drug detail

Brand nameEnbrel
Active ingredientetanercept
Strength50MG/ML
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
Marketing statusRx

More from Immunex Corporation

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

Enbrel patent cliff — loss of exclusivity — | CliffBio